---
source: Solstice Health, Inc. SOW_Signature.pdf
type: SOWs
extracted: 2026-01-19
---

```markdown
# STATEMENT OF WORK

THIS STATEMENT OF WORK (the “SOW”), effective as of the last date of signature (the “Work Order Effective Date”), by and between Phathom Pharmaceuticals, Inc., (“Phathom”) and Solstice Health, Inc. ("Solstice") and is incorporated into and shall be governed by the Master Services Agreement by and between Phathom and Solstice dated September 5, 2025 (the “Agreement”). Each of Phathom and Solstice may be referred to herein as a “Party”, and collectively as, the “Parties”. Capitalized but undefined terms shall have the meanings first ascribed to them in the Agreement.

**SOW TERM:**
*   1 year starting on the Work Order Effective Date,
*   Automatic renew of 1 year terms until either Party notifies the other Party of non-renewal in writing at least 30 days before the end of the then-current term.

**DESCRIPTION OF PLATFORM LICENSE AND SERVICES:** Solstice will provide Authorized Users with credentials for the Platform.

1.  **Solstice Services** Solstice will provide Authorized Users with credentials for the Platform.

2.  **Access to Platform:**
    2.1. Solstice is a provider of a cloud-based Al-powered platform that is designed to assist customers with reviewing and generating certain promotional and marketing assets for life sciences marketing (the “Platform”), which includes functionality for customers to input their marketing assets, prompts, parameters, and other information (into the Platform to receive reports and feedback about such assets, modified versions of such assets, or new or additional assets. The terms Inputs, Outputs and Phathom Data as used in this Statement of Work shall have the meanings set forth in in the Agreement.

    The Platform includes the ability for customers to create new promotional and marketing assets (“Content Assistant”) as well as the ability for customers to evaluate materials to ensure its compliance with regulatory and brand guidelines (“Fact Check Assistant”). At Phathom's request, Solstice will also develop an API integration with Phathom's digital asset management system (“DAM”) to ensure streamlined content submission to promotional review committees.

    Subject to the terms and conditions of the Agreement, Solstice will provide Phathom's authorized employees and Phathom consultant users (each, an “Authorized User”) with credentials to use the Platform

    2.2. In addition to the Platform, Solstice will provide a dedicated technical account personnel to provide technical support and manage the use of the system at Phathom's request (“Managed Services”). This individual will provide technical support and act as the liaison between Phathom and the Solstice team to address any personalization requests. At Phathom's request, in addition to the Phathom Authorized Users, Solstice personnel will access and use the Platform as Authorized Users on Phathom's behalf.

    2.3. Phathom is solely responsible for the accuracy, quality, integrity, legality, reliability and appropriateness of all Phathom Data. Phathom represents and warrants that (a) it has made all disclosures, provided all notices, and has obtained all rights, consents, and permissions necessary for Solstice to collect, access, use, disclose, transfer, transmit, store, host, or otherwise process (collectively, "Process”) Phathom Data as contemplated by the Agreement without violating or infringing Laws, third-party rights, or terms or policies that apply to the Phathom Data and (b) Phathom Data do not contain any of the following categories of sensitive data: (i) social security number, passport number, driver's license number, or similar identifier (or any portion thereof); (ii) credit or debit card number (other than the truncated (last four digits) of a credit or debit card), financial information, banking account numbers or passwords; (iii) employment, financial, genetic, biometric or health information; (iv) racial, ethnic, political or religious affiliation, trade union membership, or information about sexual life or sexual orientation; (v) account passwords, mother's maiden name, or date of birth; (vi) criminal history; (vii) any other information or combinations of information that falls within the definition of "special categories of data,” "sensitive data” or “sensitive personal information” under any applicable law or regulation relating to privacy or data protection; or (viii) personal information of children under the age of 16.

    2.4. Solstice may Process performance, analytical, or usage data relating to Phathom's access to or use of the Platform (“Usage Data”) and Phathom Data that has been deidentified or aggregated with other data such that the resulting data no longer reasonably identifies Phathom or a specific individual ("Aggregated Data") for internal business purposes, such as to: (a) track use of the Platform for billing purposes; (b) provide support for Services; (c) monitor the performance and stability of the Platform; (d) prevent or address technical issues with the Platform; (e) to improve the Platform, Solstice's other products and services, and to develop new products and services; and (f) for all other lawful business internal operational practices, such as analytics, benchmarking, and reports. Feedback, Usage Data, and Aggregated Data will be Solstice's, and not Phathom's, property and Confidential Information.

    2.5. Notwithstanding anything to the contrary, Solstice agrees that it shall not use, and shall ensure third-party providers of large language models (LLMs) incorporated into the Platform (“Third-Party LLM Providers”) do not use, any Inputs, other Phathom Data or Outputs to train any machine learning, deep learning, or statistical learning algorithms, LLMs, neural networks, or models.

3.  **Termination:**
    3.1. If the Agreement or this SOW are terminated for any reason, Phathom will promptly cease all use of the Platform.

    3.2. Phathom may terminate this SOW at any time by providing Solstice with at least thirty days prior written notice thereof, provided that if Phathom terminates this SOW pursuant to this Section 3.2, Phathom will pay Solstice an Early Termination Fee of $9,000 within 30 days of the effective date of termination.

    3.3. Nothing contained in this Agreement nor any disclosure or provision to Solstice of any Phathom Confidential Information or other Phathom materials or items shall be deemed to transfer or grant to Solstice or any other person or entity any right to use or exploit such information, materials or items nor provide any right, title, interest, or license in, to or under any patent, patent application or other intellectual property, right or asset of Phathom, including without limitation, Phathom Confidential Information, any improvements, discoveries, know-how, inventions and other insights, whether patentable or not. Notwithstanding the foregoing, Phathom may (but is not obligated to) provide suggestions, comments or other feedback to Solstice with respect to the Services, including the Platform (“Feedback") and Solstice may freely use and exploit such Feedback.

    3.4. Phathom represents and warrants that it shall not and shall not permit or assist anyone else to directly or indirectly: (a) rent, lease, or otherwise permit third parties to use the Platform; (b) use the Platform, to provide services to third parties (e.g., as a service bureau); (c) disclose the results of any benchmarking of the Platform, or use such results for its own competing software development activities, such as to build a product or application that is competitive with any Solstice products or any third-party LLM; (d) attempt to bypass, circumvent, or disable any technological or security features or measures in the Platform; (e) use the Platform, in violation of any applicable laws or regulations; (f) reverse engineer, decompile, disassemble, or otherwise attempt to discover the source code, object code, or underlying structure, ideas, or algorithms of the Platform, (except to the extent applicable laws specifically prohibit such restriction); (g) modify, translate, or create derivative works based on the Platform; (h) copy, rent, lease, distribute, pledge, assign, or otherwise transfer or encumber rights to the Platform; (i) remove or otherwise alter any proprietary notices or labels from the Platform, or any portion thereof; (j) interfere or attempt to interfere with the proper working of the Platform,; (k) represent that any Output is human-generated; or (l) “crawl,” “scrape,” or “spider” any page, data, or portion of or relating to the Platform (or any information, data or content made available through the Platform), whether through use of manual or automated means. Phathom is solely responsible for all of Phathom's activity in connection with use of the Platform, and all activity associated with Platform's user accounts provisioned to Phathom, including but not limited to uploading Phathom Data onto the Platform. Phathom shall use the Platform, in compliance with the Agreement, this SOW and all applicable local, state, national and foreign laws, treaties and regulations and all applicable rules and professional standards (collectively, “Laws"). Phathom represents and warrants that it shall not use the Platform, in a manner that is harmful, deceptive, threatening, harassing or obscene and shall not use Phathom Data in any way that violates any third-party intellectual property, contractual or other proprietary rights.

    3.5. Phathom acknowledges that Solstice may engage certain outsourced technology vendors, independent contractors (e.g. outsourced copywriters), providers of third-party large language models (LLMs), or other service providers on an enterprise-basis in connection with Solstice's operations (collectively, “Technology Vendors”) (e.g., cloud hosting providers, PEOs or staff augmentation providers), and nothing herein will be deemed to prohibit or limit Solstice's ability to engage any Technology Vendors. Solstice shall be responsible for ensuring that Technology Vendors comply with the terms of the Agreement and this SOW.

4.  **FEES:**
    A.  **Fees.** In consideration for the Services that Solstice performs pursuant to this SOW, as described in Section 1 of this SOW, Phathom shall pay Solstice the following fees (“Fees”) during the term of the SOW:

        i.  $9,000 per month per Brand, paid monthly
        ii. $10,000 implementation fee per Brand, paid one time per Brand

    B.  **Platform License Up to 5 Brands**

        As used in this SOW, “Brand” means a Phathom product or service sold under a distinctive name regardless of the number of indications for which it is sold. As used in this SOW, VOQUEZNA tablets, VOQUEZNA DualPak and VOQUEZNA TriplePak shall all be considered a single Brand.

        Use of the Platform and Services beyond the term of this SOW or for more than 5 Brands shall require the Parties to mutually agree to and enter into a new SOW with terms therefor.

    C.  **Expenses.** Phathom shall reimburse Solstice for reasonable, pre-approved pass-through and out-of-pocket expenses for the following that are actually incurred by Solstice in connection with the Services that are expressly agreed to by Phathom in writing in advance (“Authorized Expenses”).

    D.  **Payment Terms and Schedule.** Solstice may invoice Phathom for the Fees monthly in advance for the applicable service month; provided that the one-time implementation fee will be invoiced prior to onboarding the applicable Brand. Invoices shall be sent via e-mail in portable document format (i.e., .pdf), to phathom.ap@phathompharma.com. Alternatively, invoices may be directed to the attention of Accounts Payable. Phathom shall pay each invoice it receives from Solstice in accordance with the terms of the Agreement. The fees set forth in this SOW are due during the term of the SOW regardless of whether or not Phathom decides to use the Platform as set forth in this SOW during the applicable month. Solstice may suspend performance of the Services during any period of non-payment or late payment.

    E.  **Additional Work.** Phathom may incur additional Fees and expenses if it requests Solstice to perform services that are materially different than, or in addition to, those described in this SOW (the “Additional Work"). Prior to commencing any such Additional Work or incurring any expenses in connection with the Additional Work, Solstice will notify Phathom that the requested services are outside of the scope of this SOW, will provide a fee estimate to Phathom, and will obtain Phathom's prior written approval.

5.  **MISCELLANEOUS.**
    A.  **Contact.** For purposes of this SOW, Phathom's contact shall be:

        Leona Ling, Director, Marketing
        Phathom Pharmaceuticals, Inc.
        100 Campus Drive, Suite 103
        Florham Park, NJ 07932
        Email: lling@phathompharma.com
        Tel: 609-903-8577

    B.  **Amendments.** This SOW may not be amended or modified in any manner except by an instrument in writing signed by the Parties hereto.

    C.  **Counterparts.** This SOW incorporated may be executed in one (1) or more duplicate originals, all of which together shall be deemed one and the same instrument. Execution of this SOW by facsimile, by email in portable document format (i.e., .pdf), or by any other electronic means intended to preserve the original graphic and pictorial appearance of the Agreement or this SOW, as applicable, shall be binding to the same extent as physical delivery of the paper document bearing original signature.

**AGREED AND ACKNOWLEDGED:**

**PHATHOM PHARMACEUTICALS, INC.**

By: Susan Kim
Name: Susan Kim
Title: VP of Marketing
Date: 08-Sep-2025

**SOLSTICE HEALTH, INC.**

By: Yiwen Li
Name: Yiwen Li
Title: Co-Founder & Chief Operating Officer
Date: 08-Sep-2025
```
